Pharma Tech Industries Revenue and Competitors
Estimated Revenue & Valuation
- Pharma Tech Industries's estimated annual revenue is currently $80M per year.
- Pharma Tech Industries's estimated revenue per employee is $201,000
Employee Data
- Pharma Tech Industries has 398 Employees.
- Pharma Tech Industries grew their employee count by -1% last year.
Pharma Tech Industries's People
Name | Title | Email/Phone |
---|---|---|
1 | Interim CEO | Reveal Email/Phone |
2 | VP Finance | Reveal Email/Phone |
3 | VP Quality & Regulatory Affairs at Pharma Tech Industries | Reveal Email/Phone |
4 | SVP Operations | Reveal Email/Phone |
5 | Director Quality | Reveal Email/Phone |
6 | Site Director | Reveal Email/Phone |
7 | Corporate Quality Director | Reveal Email/Phone |
8 | Director Procurement | Reveal Email/Phone |
9 | Senior Director Supply Chain Management | Reveal Email/Phone |
10 | Chief Commercial Officer | Reveal Email/Phone |
Pharma Tech Industries Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $24.5M | 122 | 8% | N/A | N/A |
#2 | $10.7M | 53 | -17% | N/A | N/A |
#3 | $9.2M | 46 | 2% | N/A | N/A |
#4 | $24.1M | 120 | 5% | N/A | N/A |
#5 | $7.2M | 36 | -20% | N/A | N/A |
#6 | $27.7M | 138 | -30% | N/A | N/A |
#7 | $39.8M | 198 | 37% | N/A | N/A |
#8 | $0.5M | 5 | 25% | $50M | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $10.3M | 51 | 11% | N/A | N/A |
What Is Pharma Tech Industries?
Pharma Tech Industries is a family owned and operated pharmaceutical contract manufacturing organization offering fully-integrated supply chain support and highly customized production services to many of the most trusted pharmaceutical and wellness companies in the world. We filled our first products in 1972 in the small town of Union, Missouri and, over the next 40 years, grew to be the largest pharmaceutical contract manufacturer and packager of powder products. From initial technology transfer through manufacturing and packaging in a variety of platforms - including topical, oral ingestible, inhalation, and oral health - we provide true end-to-end supply chain fulfillment services and solutions across the wellness, OTC, Rx and Class I Medical Device regulatory segments. While the roots of our production capabilities lie in powder based products, we have expanded into other complex dosage forms including effervescent products and drug device combinations including powders, liquids, and gases. Our broad technology transfer capabilities allow us the flexibility to offer customers tailored ?plant-within-a-plant? solutions. Today, our customers include six of the top ten global pharmaceutical corporations as well as numerous other virtual and emerging technology- based organizations, and our average customer tenure is over ten years. Unlike other contract manufacturers, our people and our culture are our biggest assets. The foundation of these assets is five key values that we call "The PTI Way:" Integrity, Stewardship, Humility, Optimism, and Working Together. We continue to expand our capabilities through technology transfer and strategic expansion. Our current footprint includes over 460,000 square feet of cGMP production space, and more than 400 employees across two state-of-the-art facilities in Royston, Georgia and Union, Missouri, with corporate offices in Athens, Georgia.
keywords:N/AN/A
Total Funding
398
Number of Employees
$80M
Revenue (est)
-1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pharma Tech Industries News
Now, however, the focus has switched to higher value, higher tech sectors, such as pharmaceuticals, aerospace and the automotive sector,...
... at the Institute of Technology Management at University of St. Gallen about their recent papers covering pharma R&D productivity.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $35M | 400 | N/A | N/A |
#2 | $177.5M | 433 | 5% | N/A |
#3 | $100.1M | 445 | N/A | N/A |
#4 | $75M | 458 | N/A | N/A |
#5 | $35M | 490 | 9% | N/A |